Skip to content

Comparison of herbal gum application and astringent gum paint, each combined with bloodletting, for patients with gum disease (gingivitis)

A RANDOMIZED COMPARATIVE CLINICAL TRIAL ON THE EFFICACY OF PRIYANGAVADI CHURNA PRATISARANA AND ASTRINGENT GUM PAINT EACH COMBINED WITH RAKTAMOKSHANA IN THE MANAGEMENT OF SHITADA W.S.R. TO GINGIVITIS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093652
Enrollment
100
Registered
2025-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

None listed

Sponsors

National Institute of Ayurveda (Deemed to be University)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged between eighteen to fifty years presenting with clinical signs and symptoms of Shitada also known as Gingivitis as described in Ayurveda and Modern Science will be included in the study. The diagnosis of the disease will be based on the presence of signs and symptoms of Shitada and the Gingival Index score. Shitada lakshana (clinical features): Spontaneous bleeding from gums, inflammation, discoloration of gums, bad breath, pain, moistening of gums, pus discharge, and spongy gums. Gingival Index criteria: Patients scoring between one and two indicating mild to moderate gingivitis on the Gingival Index will be included.

Exclusion criteria

Exclusion criteria: Patients below eighteen years of age and above sixty years of age will be excluded from the study. Patients with periodontal pockets associated with pus discharge will be excluded. Patients with evidence of malignancy, human immunodeficiency virus infection, or uncontrolled diabetes mellitus will be excluded. Patients suffering from systemic disorders which may alter the outcome of the study such as haemophilia or other bleeding disorders will be excluded. Pregnant women will not be included in the study. Patients who are using anticoagulant drugs such as aspirin will be excluded. Patients taking any other systemic drugs which can alter the outcome of the study will also be excluded.

Design outcomes

Primary

MeasureTime frame
Change in Gingival Index and Sulcus Bleeding Index measured at baseline and after four weeks of intervention.Timepoint: Primary outcome will be assessed at specific time points: Baseline (0 week), 4 weeks, and 8 weeks.

Secondary

MeasureTime frame
Change in the signs & symptoms of Shitada namely spontaneous bleeding from gums, pain, foul smell from mouth, inflammation, blackish discoloration of gums, moistening of gums, pus discharge, & sponginess of gums assessed at baseline & after four weeks of intervention.Timepoint: Secondary outcomes will be assessed at baseline 0 week, 4 weeks & 8 weeks

Countries

India

Contacts

Public ContactDr Hemant Kumar Nagar

NATIONAL INSTITUTE OF AYURVEDA

pamnani.gulab@gmail.com9461154942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026